Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer.
Said, Rabih
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. [electronic resource] - Cancer chemotherapy and pharmacology 05 2016 - 1097-102 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1432-0843
10.1007/s00280-016-3000-3 doi
Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bevacizumab--administration & dosage
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Injections, Intravenous
Lenalidomide
Male
Maximum Tolerated Dose
Melanoma--drug therapy
Middle Aged
Response Evaluation Criteria in Solid Tumors
Thalidomide--administration & dosage
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. [electronic resource] - Cancer chemotherapy and pharmacology 05 2016 - 1097-102 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1432-0843
10.1007/s00280-016-3000-3 doi
Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bevacizumab--administration & dosage
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Injections, Intravenous
Lenalidomide
Male
Maximum Tolerated Dose
Melanoma--drug therapy
Middle Aged
Response Evaluation Criteria in Solid Tumors
Thalidomide--administration & dosage